NO995745L - Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medikamenter - Google Patents

Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medikamenter

Info

Publication number
NO995745L
NO995745L NO995745A NO995745A NO995745L NO 995745 L NO995745 L NO 995745L NO 995745 A NO995745 A NO 995745A NO 995745 A NO995745 A NO 995745A NO 995745 L NO995745 L NO 995745L
Authority
NO
Norway
Prior art keywords
erythromycin
medicaments
preparation
new derivatives
derivatives
Prior art date
Application number
NO995745A
Other languages
English (en)
Other versions
NO995745D0 (no
NO314729B1 (no
Inventor
Chimiste Cadre
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO995745D0 publication Critical patent/NO995745D0/no
Publication of NO995745L publication Critical patent/NO995745L/no
Publication of NO314729B1 publication Critical patent/NO314729B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO19995745A 1998-11-24 1999-11-23 Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, medikamenter som inneholder disse, samt nye forbindelser som ermellomprodukter vedfremstillingen av derivatene NO314729B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (3)

Publication Number Publication Date
NO995745D0 NO995745D0 (no) 1999-11-23
NO995745L true NO995745L (no) 2000-05-25
NO314729B1 NO314729B1 (no) 2003-05-12

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995745A NO314729B1 (no) 1998-11-24 1999-11-23 Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, medikamenter som inneholder disse, samt nye forbindelser som ermellomprodukter vedfremstillingen av derivatene

Country Status (24)

Country Link
US (2) US6440941B1 (no)
EP (1) EP1004592B1 (no)
JP (1) JP2000159790A (no)
KR (1) KR100587445B1 (no)
CN (1) CN1165546C (no)
AR (1) AR021388A1 (no)
AT (1) ATE245160T1 (no)
AU (1) AU772171B2 (no)
BR (1) BR9905735A (no)
CA (1) CA2290136C (no)
DE (1) DE69909577T2 (no)
DK (1) DK1004592T3 (no)
ES (1) ES2198867T3 (no)
FR (1) FR2786188B1 (no)
HU (1) HUP9904392A3 (no)
IL (1) IL133101A (no)
MX (1) MXPA99010813A (no)
NO (1) NO314729B1 (no)
PL (1) PL336736A1 (no)
PT (1) PT1004592E (no)
RU (1) RU2237672C2 (no)
TR (1) TR199902888A3 (no)
TW (1) TWI247747B (no)
ZA (1) ZA997176B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
DE60104240T2 (de) 2000-06-30 2005-08-04 Pfizer Products Inc., Groton Makrolid-Antibiotika
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2009137787A1 (en) * 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
AU2009308182B2 (en) * 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
CN105198944B (zh) 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
WO2012052412A1 (de) 2010-10-22 2012-04-26 Bayer Cropscience Ag Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CZ9904388A3 (cs) * 1997-06-11 2002-10-16 Pfizer Products Inc. 9-Oximové deriváty erythromycinu
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Also Published As

Publication number Publication date
MXPA99010813A (es) 2005-09-08
AU5952299A (en) 2000-05-25
IL133101A (en) 2007-02-11
FR2786188A1 (fr) 2000-05-26
ZA997176B (en) 2000-11-20
CN1165546C (zh) 2004-09-08
TR199902888A2 (xx) 2000-06-21
ES2198867T3 (es) 2004-02-01
NO995745D0 (no) 1999-11-23
US6664398B2 (en) 2003-12-16
TR199902888A3 (tr) 2000-06-21
JP2000159790A (ja) 2000-06-13
NO314729B1 (no) 2003-05-12
CN1263101A (zh) 2000-08-16
RU2237672C2 (ru) 2004-10-10
KR100587445B1 (ko) 2006-06-08
FR2786188B1 (fr) 2002-10-31
US6440941B1 (en) 2002-08-27
EP1004592B1 (fr) 2003-07-16
US20030050254A1 (en) 2003-03-13
DE69909577D1 (de) 2003-08-21
TWI247747B (en) 2006-01-21
HUP9904392A3 (en) 2001-08-28
HU9904392D0 (en) 2000-01-28
CA2290136A1 (fr) 2000-05-24
AU772171B2 (en) 2004-04-08
HUP9904392A2 (hu) 2000-05-28
PT1004592E (pt) 2003-12-31
CA2290136C (fr) 2010-07-20
IL133101A0 (en) 2001-03-19
DE69909577T2 (de) 2004-06-03
EP1004592A1 (fr) 2000-05-31
ATE245160T1 (de) 2003-08-15
KR20000057017A (ko) 2000-09-15
AR021388A1 (es) 2002-07-17
PL336736A1 (en) 2000-06-05
DK1004592T3 (da) 2003-10-27
BR9905735A (pt) 2000-08-08

Similar Documents

Publication Publication Date Title
NO995745L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medikamenter
NO954942L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
DK0680967T3 (da) Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO20006251D0 (no) Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO20003496L (no) Nye aromatiske amider, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medisiner
DK1016669T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO983955D0 (no) Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler
NO20032733D0 (no) Difenyl azetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO993003L (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO20020687L (no) 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
NO20000294D0 (no) Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler
NO20010568D0 (no) Substituerte imidazo[1,2a]aziner som selektive inhibitorer for cox-2
NO20003661L (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
NO990302L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av slike, samt deres anvendelse som medikamenter
NO985790D0 (no) Nye aromatiske derivater substituert med ribose, fremgangsmÕte for fremstilling derav samt deres anvendelse som medikamenter
NO992859D0 (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
NO20004638L (no) Hypnotisk <beta>- karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt
NO20024590D0 (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
NO993124D0 (no) Nye erytromycinderivater, fremgangsmÕte for fremstilling av disse samt deres anvendelse som medisiner
NO990675L (no) 11-acetyl-12,13-dioksabisyklo[8.2.1.]-tridekenonderivater, fremgangsmåter for deres fremstilling, samt legemidler inneholdende slike forbindelser
NO972434D0 (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO984547D0 (no) Nye oksazolidinderivater, fremgangsmÕte for deres fremstilling, samt legemidler inneholdende disse forbindelser
NO963129L (no) Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler
NO20006573L (no) Nye 17-halogenerte 19-nor-steroider, metode og mellomprodukter for fremstilling av disse, anvendelse som medisiner og farmasöytiske preparater inneholdende disse